STRATEGIES FOR EQUITABLE PHARMACOGENOMIC-GUIDED WARFARIN DOSING AMONG EUROPEAN AND AFRICAN AMERICAN INDIVIDUALS IN A CLINICAL POPULATION

The blood thinner warfarin has a narrow therapeutic range and high inter- and intra-patient variability in therapeutic doses. Several studies have shown that pharmacogenomic variants help predict stable warfarin dosing. However, retrospective and randomized controlled trials that employ dosing algor...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pac Symp Biocomput
Hlavní autoři: WILEY, LAURA K., VANHOUTEN, JACOB P., SAMUELS, DAVID C., ALDRICH, MELINDA C., RODEN, DAN M., PETERSON, JOSH F., DENNY, JOSHUA C.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5389380/
https://ncbi.nlm.nih.gov/pubmed/27897005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky